BACKGROUND: In head and neck squamous cell carcinoma (HNSCC), the occurrence of concurrent lung malignancies poses a significant diagnostic challenge because metastatic HNSCC is difficult to discern from second primary lung squamous cell carcinoma (SCC). However, this differentiation is crucial because the recommended treatments for metastatic HNSCC and second primary lung SCC differ profoundly. METHODS: We analyzed the origin of lung tumors in 32 patients with HNSCC using human papillomavirus (HPV) typing and targeted next generation sequencing of all coding exons of tumor protein 53 (TP53). RESULTS: Lung tumors were clearly identified as HNSCC metastases or second primary tumors in 29 patients, thus revealing that 16 patients had received incorrect diagnoses based on clinical and morphological data alone. CONCLUSION: The HPV typing and mutation analysis of all TP53 coding exons is a valuable diagnostic tool in patients with HNSCC and concurrent lung SCC, which can help to ensure that patients receive the most suitable treatment.
- Daher, T.
- Tur, M. K.
- Brobeil, A.
- Etschmann, B.
- Witte, B.
- Engenhart-Cabillic, R.
- Krombach, G.
- Blau, W.
- Grimminger, F.
- Seeger, W.
- Klussmann, J. P.
- Brauninger, A.
- Gattenlohner, S.
Keywords
- head and neck cancer metastasis
- human papillomavirus (HPV)
- lung cancer
- next generation sequencing
- p53
